Second-Line Chemotherapy Efficacy In Patients With Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis Of 192 Patients From Nej023 Study.

Shunichiro Iwasawa,Ryo Ko,Takehito Shukuya,Satoshi Watanabe,Yoko Tsukita,Hironori Ashinuma,Taku Nakagawa,Ryo Ito,Kazutsugu Uematsu,Mika Nakao,Yoshiaki Mori,Kyoichi Kaira,Atsuto Mouri,Takao Miyabayashi,Hiroyuki Sakashita,Yoko Matsumoto,Tomoyuki Tanigawa,Satoshi Morita,Kazuhisa Takahashi

JOURNAL OF CLINICAL ONCOLOGY（2016）

引用 0|浏览10

暂无评分

摘要

8569Background: Thymic carcinoma is a rare neoplasm. Minimal information exists regarding second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma. Methods: W...

查看译文

关键词

advanced thymic carcinoma,chemotherapy,efficacy,second-line

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要